Global survey on surgeon preference and current practice for pancreatic neck and body cancer with portomesenteric venous involvement
- PMID: 40204592
- DOI: 10.1016/j.hpb.2025.03.005
Global survey on surgeon preference and current practice for pancreatic neck and body cancer with portomesenteric venous involvement
Abstract
Background: Evidence regarding the optimal surgical approach for pancreatic neck/body cancer with portomesenteric vein (PV) involvement is scarce. We aimed to clarify the current practice using an international survey.
Methods: An online survey was distributed to members of nine international associations and study groups. Surgeons who performed pancreatectomy with PV resection (PVR) in the last 12 months were asked about three clinical scenarios with different PV involvement: scenarios A (<90°; length 1 cm), B (<90°; length 3 cm), and C (90-180°; length 3 cm), with or without common hepatic artery (CHA) involvement. PVR was defined according to the ISGPS definition.
Results: Overall, 222 surgeons from 49 countries in 6 continents completed the survey. The most selected procedures were left pancreatectomy with PVR ISGPS-type 1 for scenario A (52.3 %), PVR ISGPS-type 2 for B (28.8 %), and pancreatoduodenectomy with PVR ISGPS-type 3 for C (28.4 %). In patients with CHA involvement, the most selected procedures were left pancreatectomy without arterial reconstruction for A (57.7 %) and B (50.0 %), and total pancreatectomy for C (29.7 %).
Conclusions: The survey illustrates the heterogeneity in surgical management of pancreatic neck/body cancer with PV involvement, indicating the need for prospective studies and guidelines.
Copyright © 2025 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflict of interest Marco Del Chiaro received an industry grant (Haemonetics, Inc) to conduct a multicenter study and is a co-principal investigator of an international multicenter study sponsored by Boston Scientific. Richard D. Schulick is a co-inventor of a patent licensed to DynamiCure (managed by the University of Colorado). Sohei Satoi received three grants from Nihon Servier, Amino Up Co., and Boston Scientific. Atsushi Oba has been awarded a grant (Bayer Yakuhin, Ltd.) to conduct an observational study to investigate the clinical impact of EOB-MRI. No other disclosures were reported from the other authors.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
